adamantane has been researched along with Constriction, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Derkach, VA; Smith, PA | 1 |
| Garvey, DS; Janero, DR; Letts, LG; Lin, CE; Marek, P; Richardson, SK; Serebryanik, D; Shumway, MJ; Tam, SW; Trocha, AM; Young, DV | 1 |
2 other study(ies) available for adamantane and Constriction, Pathological
| Article | Year |
|---|---|
Loss of Ca(2+)-permeable AMPA receptors in synapses of tonic firing substantia gelatinosa neurons in the chronic constriction injury model of neuropathic pain.
Topics: Adamantane; Animals; Calcium; Constriction, Pathologic; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Male; Neuralgia; Neurons; Rats; Receptors, AMPA; Spinal Cord; Substantia Gelatinosa; Synapses | 2016 |
Combination of paclitaxel and nitric oxide as a novel treatment for the reduction of restenosis.
Topics: Adamantane; Animals; Antineoplastic Agents; Constriction, Pathologic; Iliac Artery; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Paclitaxel; Platelet Aggregation Inhibitors; Rabbits; Recurrence; Stents; Vascular Diseases | 2004 |